Dofequidar is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar has highly potent reversing effect on multidrug-resistant tumor cells.
Molecular Weight:
481.59
Purity:
>98.0%
CAS Number:
[129716-58-1]
Formula:
C30H31N3O3
Target:
P-glycoprotein
* VAT and and shipping costs not included. Errors and price changes excepted